 |  | | ABOUT US | |
| | PRODUCT | |
 | | PIPELINE | |
| | INVESTOR RELATIONS | |
| | NEWS | |
| | CAREERS | |
| | | | | | | |||||||||||||||||||||
 | |||||||||||||||||||||||||||
 | |||||||||||||||||||||||||||
|
| |
Our core development programs are focused in the areas of pulmonology and hepatology. In pulmonology, we are developing therapies for the treatment of idiopathic pulmonary fibrosis. In hepatology, we are developing therapies focused on expanding treatment options for patients suffering from chronic hepatitis C. | |
| |
|||||||||||||||||||||
| © InterMune 2004 | Terms and Conditions | Privacy Policy | |
| | | | |